vs

Side-by-side financial comparison of Meridian Corp (MRBK) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

Meridian Corp is the larger business by last-quarter revenue ($34.2M vs $21.8M, roughly 1.6× NEKTAR THERAPEUTICS). Meridian Corp runs the higher net margin — 428.0% vs -165.4%, a 593.4% gap on every dollar of revenue. On growth, Meridian Corp posted the faster year-over-year revenue change (5.1% vs -25.3%). Meridian Corp produced more free cash flow last quarter ($22.6M vs $-65.0M). Over the past eight quarters, Meridian Corp's revenue compounded faster (18.0% CAGR vs 0.4%).

Meridian Audio is a consumer audio and home theatre equipment manufacturer based in the United Kingdom. Bob Stuart and Allen Boothroyd founded the company in 1977 under the name Boothroyd-Stuart. In 1985 the company released a CD player under the brand name, Meridian. The company also created the lossless compression format Meridian Lossless Packing in 1998 and the lossy Master Quality Authenticated (MQA) format in 2014.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

MRBK vs NKTR — Head-to-Head

Bigger by revenue
MRBK
MRBK
1.6× larger
MRBK
$34.2M
$21.8M
NKTR
Growing faster (revenue YoY)
MRBK
MRBK
+30.4% gap
MRBK
5.1%
-25.3%
NKTR
Higher net margin
MRBK
MRBK
593.4% more per $
MRBK
428.0%
-165.4%
NKTR
More free cash flow
MRBK
MRBK
$87.5M more FCF
MRBK
$22.6M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
MRBK
MRBK
Annualised
MRBK
18.0%
0.4%
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRBK
MRBK
NKTR
NKTR
Revenue
$34.2M
$21.8M
Net Profit
$7.2M
$-36.1M
Gross Margin
Operating Margin
27.2%
-126.9%
Net Margin
428.0%
-165.4%
Revenue YoY
5.1%
-25.3%
Net Profit YoY
28.3%
-596.9%
EPS (diluted)
$0.61
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRBK
MRBK
NKTR
NKTR
Q4 25
$34.2M
$21.8M
Q3 25
$33.1M
$11.8M
Q2 25
$32.4M
$11.2M
Q1 25
$27.1M
$10.5M
Q4 24
$32.6M
$29.2M
Q3 24
$29.1M
$24.1M
Q2 24
$26.1M
$23.5M
Q1 24
$24.6M
$21.6M
Net Profit
MRBK
MRBK
NKTR
NKTR
Q4 25
$7.2M
$-36.1M
Q3 25
$6.7M
$-35.5M
Q2 25
$5.6M
$-41.6M
Q1 25
$2.4M
$-50.9M
Q4 24
$5.6M
$7.3M
Q3 24
$4.7M
$-37.1M
Q2 24
$3.3M
$-52.4M
Q1 24
$2.7M
$-36.8M
Gross Margin
MRBK
MRBK
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
MRBK
MRBK
NKTR
NKTR
Q4 25
27.2%
-126.9%
Q3 25
26.2%
-268.6%
Q2 25
22.5%
-324.2%
Q1 25
11.6%
-425.8%
Q4 24
23.3%
49.2%
Q3 24
21.5%
-142.4%
Q2 24
16.8%
-211.9%
Q1 24
14.4%
-163.7%
Net Margin
MRBK
MRBK
NKTR
NKTR
Q4 25
428.0%
-165.4%
Q3 25
20.1%
-301.3%
Q2 25
17.2%
-372.2%
Q1 25
8.9%
-486.4%
Q4 24
366.8%
24.9%
Q3 24
16.3%
-153.6%
Q2 24
12.7%
-222.9%
Q1 24
10.9%
-170.1%
EPS (diluted)
MRBK
MRBK
NKTR
NKTR
Q4 25
$0.61
$-4.67
Q3 25
$0.58
$-1.87
Q2 25
$0.49
$-2.95
Q1 25
$0.21
$-0.24
Q4 24
$0.49
$-2.07
Q3 24
$0.42
$-2.66
Q2 24
$0.30
$-3.76
Q1 24
$0.24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRBK
MRBK
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$199.7M
$89.8M
Total Assets
$2.6B
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRBK
MRBK
NKTR
NKTR
Q4 25
$15.1M
Q3 25
$41.0M
Q2 25
$43.0M
Q1 25
$38.9M
Q4 24
$44.3M
Q3 24
$30.1M
Q2 24
$27.9M
Q1 24
$48.6M
Stockholders' Equity
MRBK
MRBK
NKTR
NKTR
Q4 25
$199.7M
$89.8M
Q3 25
$188.0M
$85.1M
Q2 25
$178.0M
$-24.2M
Q1 25
$173.6M
$13.7M
Q4 24
$171.5M
$60.7M
Q3 24
$167.4M
$48.9M
Q2 24
$162.4M
$79.7M
Q1 24
$159.9M
$126.7M
Total Assets
MRBK
MRBK
NKTR
NKTR
Q4 25
$2.6B
$280.4M
Q3 25
$2.5B
$301.3M
Q2 25
$2.5B
$207.5M
Q1 25
$2.5B
$256.2M
Q4 24
$2.4B
$303.9M
Q3 24
$2.4B
$308.0M
Q2 24
$2.4B
$343.3M
Q1 24
$2.3B
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRBK
MRBK
NKTR
NKTR
Operating Cash FlowLast quarter
$24.3M
$-65.0M
Free Cash FlowOCF − Capex
$22.6M
$-65.0M
FCF MarginFCF / Revenue
65.9%
-298.0%
Capex IntensityCapex / Revenue
5.1%
0.1%
Cash ConversionOCF / Net Profit
3.38×
TTM Free Cash FlowTrailing 4 quarters
$51.7M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRBK
MRBK
NKTR
NKTR
Q4 25
$24.3M
$-65.0M
Q3 25
$24.4M
$-48.8M
Q2 25
$-12.0M
$-45.7M
Q1 25
$18.1M
$-49.1M
Q4 24
$9.6M
$-46.2M
Q3 24
$31.2M
$-43.9M
Q2 24
$-19.2M
$-37.7M
Q1 24
$-1.7M
$-47.9M
Free Cash Flow
MRBK
MRBK
NKTR
NKTR
Q4 25
$22.6M
$-65.0M
Q3 25
$24.0M
$-48.9M
Q2 25
$-12.7M
$-45.8M
Q1 25
$17.9M
$-49.1M
Q4 24
$9.0M
$-46.6M
Q3 24
$29.5M
$-44.6M
Q2 24
$-19.3M
$-37.9M
Q1 24
$-3.6M
$-48.0M
FCF Margin
MRBK
MRBK
NKTR
NKTR
Q4 25
65.9%
-298.0%
Q3 25
72.4%
-414.5%
Q2 25
-39.1%
-409.6%
Q1 25
65.9%
-469.0%
Q4 24
27.7%
-159.9%
Q3 24
101.4%
-184.9%
Q2 24
-73.8%
-161.3%
Q1 24
-14.7%
-222.0%
Capex Intensity
MRBK
MRBK
NKTR
NKTR
Q4 25
5.1%
0.1%
Q3 25
1.4%
1.0%
Q2 25
1.9%
0.3%
Q1 25
1.0%
0.0%
Q4 24
1.7%
1.6%
Q3 24
6.0%
2.8%
Q2 24
0.2%
0.8%
Q1 24
7.8%
0.7%
Cash Conversion
MRBK
MRBK
NKTR
NKTR
Q4 25
3.38×
Q3 25
3.66×
Q2 25
-2.15×
Q1 25
7.55×
Q4 24
1.71×
-6.36×
Q3 24
6.58×
Q2 24
-5.78×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons